
    
      Approximately 40% of cases of Frontotemporal lobar Degeneration (FTLD) are also associated
      with abnormal deposition of tau protein. The purpose of this study is to image MAPT mutation
      carriers and their non-carrier relatives in order to study the use of this tracer as a
      biomarker in Frontotemporal Lobar Degeneration with tau deposition (FTLD-tau).
    
  